Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-31

Clinical Trial Update: Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

View source ↗

Summary

An observational study sponsored by Novo Nordisk evaluates blood glucose control in people with diabetes using modern insulin; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (modern insulin) (insulin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED